A therapy impact questionnaire for quality-of-life assessment in advanced cancer research

M. Tamburini, S. Rosso, A. Gamba, E. Mencaglia, F. De Conno, V. Ventafridda

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

The first part of the validation procedure used for a Therapy Impact Questionnaire (TIQ) on quality-of-life assessment in advanced cancer patients is described. The TIQ is composed of 36 items which assess both disease and therapy impact according to four dimensions that operationally define quality of life: physical symptoms (24 items), functional status (3 items), concomitant emotional and cognitive factors (6 items) and social interaction (2 items). A global judgement expressed as 'have you been feeling ill' further completes the TIQ. Patients answered each question using a 4-point verbal Likert scale: not at all, slight, a lot and very much. The TIQ was given to 1,000 consecutive patients who were no longer responsive to cancer treatment and presented symptoms due to disease progression. The compliance rate was quite high (87%). Results of confirmatory factor analysis were consistent with the operational dimensions identified during questionnaire construction. In particular, the dichotomized answers to 3 functional status items could be used as a Guttman scale. In a sub-sample of 50 patients, the reproducibility of functional status items was assessed using a 7-item parallel form. The intraclass correlation coefficient obtained indicated a reasonably high reproducibility. On the basis of the analyses conducted, the TIQ appears to be a reliable and concise instrument for studies aimed to assess the effectiveness of therapies in advanced cancer patients.

Original languageEnglish
Pages (from-to)565-570
Number of pages6
JournalAnnals of Oncology
Volume3
Issue number7
Publication statusPublished - 1992

Fingerprint

Quality of Life
Questionnaire
Therapy
Cancer
Oncology
Factor analysis
Research
Neoplasms
Reproducibility
Therapeutics
Intraclass Correlation Coefficient
Confirmatory Factor Analysis
Social Interaction
Surveys and Questionnaires
Quality of life
Progression
Compliance
Interpersonal Relations
Consecutive
Statistical Factor Analysis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Public Health, Environmental and Occupational Health
  • Neuropsychology and Physiological Psychology
  • Hematology

Cite this

Tamburini, M., Rosso, S., Gamba, A., Mencaglia, E., De Conno, F., & Ventafridda, V. (1992). A therapy impact questionnaire for quality-of-life assessment in advanced cancer research. Annals of Oncology, 3(7), 565-570.

A therapy impact questionnaire for quality-of-life assessment in advanced cancer research. / Tamburini, M.; Rosso, S.; Gamba, A.; Mencaglia, E.; De Conno, F.; Ventafridda, V.

In: Annals of Oncology, Vol. 3, No. 7, 1992, p. 565-570.

Research output: Contribution to journalArticle

Tamburini, M, Rosso, S, Gamba, A, Mencaglia, E, De Conno, F & Ventafridda, V 1992, 'A therapy impact questionnaire for quality-of-life assessment in advanced cancer research', Annals of Oncology, vol. 3, no. 7, pp. 565-570.
Tamburini M, Rosso S, Gamba A, Mencaglia E, De Conno F, Ventafridda V. A therapy impact questionnaire for quality-of-life assessment in advanced cancer research. Annals of Oncology. 1992;3(7):565-570.
Tamburini, M. ; Rosso, S. ; Gamba, A. ; Mencaglia, E. ; De Conno, F. ; Ventafridda, V. / A therapy impact questionnaire for quality-of-life assessment in advanced cancer research. In: Annals of Oncology. 1992 ; Vol. 3, No. 7. pp. 565-570.
@article{45399813f8b14b0c8fc35afc7635ae70,
title = "A therapy impact questionnaire for quality-of-life assessment in advanced cancer research",
abstract = "The first part of the validation procedure used for a Therapy Impact Questionnaire (TIQ) on quality-of-life assessment in advanced cancer patients is described. The TIQ is composed of 36 items which assess both disease and therapy impact according to four dimensions that operationally define quality of life: physical symptoms (24 items), functional status (3 items), concomitant emotional and cognitive factors (6 items) and social interaction (2 items). A global judgement expressed as 'have you been feeling ill' further completes the TIQ. Patients answered each question using a 4-point verbal Likert scale: not at all, slight, a lot and very much. The TIQ was given to 1,000 consecutive patients who were no longer responsive to cancer treatment and presented symptoms due to disease progression. The compliance rate was quite high (87{\%}). Results of confirmatory factor analysis were consistent with the operational dimensions identified during questionnaire construction. In particular, the dichotomized answers to 3 functional status items could be used as a Guttman scale. In a sub-sample of 50 patients, the reproducibility of functional status items was assessed using a 7-item parallel form. The intraclass correlation coefficient obtained indicated a reasonably high reproducibility. On the basis of the analyses conducted, the TIQ appears to be a reliable and concise instrument for studies aimed to assess the effectiveness of therapies in advanced cancer patients.",
author = "M. Tamburini and S. Rosso and A. Gamba and E. Mencaglia and {De Conno}, F. and V. Ventafridda",
year = "1992",
language = "English",
volume = "3",
pages = "565--570",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "7",

}

TY - JOUR

T1 - A therapy impact questionnaire for quality-of-life assessment in advanced cancer research

AU - Tamburini, M.

AU - Rosso, S.

AU - Gamba, A.

AU - Mencaglia, E.

AU - De Conno, F.

AU - Ventafridda, V.

PY - 1992

Y1 - 1992

N2 - The first part of the validation procedure used for a Therapy Impact Questionnaire (TIQ) on quality-of-life assessment in advanced cancer patients is described. The TIQ is composed of 36 items which assess both disease and therapy impact according to four dimensions that operationally define quality of life: physical symptoms (24 items), functional status (3 items), concomitant emotional and cognitive factors (6 items) and social interaction (2 items). A global judgement expressed as 'have you been feeling ill' further completes the TIQ. Patients answered each question using a 4-point verbal Likert scale: not at all, slight, a lot and very much. The TIQ was given to 1,000 consecutive patients who were no longer responsive to cancer treatment and presented symptoms due to disease progression. The compliance rate was quite high (87%). Results of confirmatory factor analysis were consistent with the operational dimensions identified during questionnaire construction. In particular, the dichotomized answers to 3 functional status items could be used as a Guttman scale. In a sub-sample of 50 patients, the reproducibility of functional status items was assessed using a 7-item parallel form. The intraclass correlation coefficient obtained indicated a reasonably high reproducibility. On the basis of the analyses conducted, the TIQ appears to be a reliable and concise instrument for studies aimed to assess the effectiveness of therapies in advanced cancer patients.

AB - The first part of the validation procedure used for a Therapy Impact Questionnaire (TIQ) on quality-of-life assessment in advanced cancer patients is described. The TIQ is composed of 36 items which assess both disease and therapy impact according to four dimensions that operationally define quality of life: physical symptoms (24 items), functional status (3 items), concomitant emotional and cognitive factors (6 items) and social interaction (2 items). A global judgement expressed as 'have you been feeling ill' further completes the TIQ. Patients answered each question using a 4-point verbal Likert scale: not at all, slight, a lot and very much. The TIQ was given to 1,000 consecutive patients who were no longer responsive to cancer treatment and presented symptoms due to disease progression. The compliance rate was quite high (87%). Results of confirmatory factor analysis were consistent with the operational dimensions identified during questionnaire construction. In particular, the dichotomized answers to 3 functional status items could be used as a Guttman scale. In a sub-sample of 50 patients, the reproducibility of functional status items was assessed using a 7-item parallel form. The intraclass correlation coefficient obtained indicated a reasonably high reproducibility. On the basis of the analyses conducted, the TIQ appears to be a reliable and concise instrument for studies aimed to assess the effectiveness of therapies in advanced cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=0026752407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026752407&partnerID=8YFLogxK

M3 - Article

C2 - 1498079

AN - SCOPUS:0026752407

VL - 3

SP - 565

EP - 570

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 7

ER -